A Randomized, Double-blind Study Comparing the Effect of Different Treatment Regimens of Intravenous Bonviva on Lumbar Bone Mineral Density in Women With Osteoporosis

Trial Profile

A Randomized, Double-blind Study Comparing the Effect of Different Treatment Regimens of Intravenous Bonviva on Lumbar Bone Mineral Density in Women With Osteoporosis

Completed
Phase of Trial: Phase III

Latest Information Update: 11 Feb 2016

At a glance

  • Drugs Ibandronic acid (Primary) ; Ibandronic acid
  • Indications Postmenopausal osteoporosis
  • Focus Pharmacodynamics
  • Acronyms DIVA; DIVA LTE
  • Sponsors Roche
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 21 Jul 2011 Actual end date of the extension trial is Nov 2008 as reported by ClinicalTrials.gov (NCT00551174).
    • 21 Jul 2011 Actual end date of the extension trial is Nov 2008 as reported by ClinicalTrials.gov (NCT00551174).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top